Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Since in most cases CLL remains an incurable disease, the goals of therapy are to improve quality of life and to prolong survival. This study will evaluate the participant's related outcomes and experience of CLL in adult participants who are treated in the Spa...
Call us @: 844 663-3742
Medical Condition
Study Phase
Intervention Type
Date
Gender
Age
Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
You can ask us questions via online form or phone call.
Call us @: 844 663-3742
Location | Status | Site Contact Details |
---|---|---|
Location HUA - Txagorritxu, Vitoria, Alava, 01009 | Status Recruiting | Site Contact Details |
Location Hospital de Cabueñes, Gijón, Asturias, 33394 | Status Recruiting | Site Contact Details |
Location Sant Joan de Deu de Manresa, Manresa, Barcelona, 08243 | Status Recruiting | Site Contact Details |
Location Hospital Universitari Mútua Terrassa, Terrassa, Barcelona, 08221 | Status Recruiting | Site Contact Details |
Location Hospital Jerez De La Frontera, Jerez de la Frontera, Cadiz, 11407 | Status Recruiting | Site Contact Details |
Location Hospital Comarcal de Laredo, Laredo, Cantabria, 39770 | Status Recruiting | Site Contact Details |
Location Hospital Universitario Marques de Valdecilla, Santander, Cantabria, 39008 | Status Recruiting | Site Contact Details |
Location Hospital Universitario Reina Sofia, Córdoba, Cordoba, 14004 | Status Recruiting | Site Contact Details |
Location Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, 35019 | Status Recruiting | Site Contact Details |
Location Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, 28942 | Status Recruiting | Site Contact Details |
Location Hospital Clinico Universitario Virgen de la Arrixaca, El Palmar, Murcia, 30120 | Status Recruiting | Site Contact Details |
Location Hospital Meixoeiro (CHUVI), Vigo, Pontevedra, 36213 | Status Recruiting | Site Contact Details |
Location Hospital Universitario de Galdakao, Galdakao, Vizcaya, 48960 | Status Recruiting | Site Contact Details |
Location Hospital de Sant Joan Despi Moises Broggi, Barcelona, 08906 | Status Recruiting | Site Contact Details |
Location Hospital Universitario Virgen de las Nieves, Granada, 18014 | Status Recruiting | Site Contact Details |
Location Hospital Lucus Augusti, Lugo, 27004 | Status Recruiting | Site Contact Details |
Location Hospital General Universitario Gregorio Maranon, Madrid, 28007 | Status Recruiting | Site Contact Details |
Location Hospital Universitario Fundacion Jimenez Diaz, Madrid, 28040 | Status Recruiting | Site Contact Details |
Location Hospital Universitario 12 de Octubre, Madrid, 28041 | Status Recruiting | Site Contact Details |
Location Hospital Universitario La Paz, Madrid, 28046 | Status Recruiting | Site Contact Details |
Location Hospital General Universitario Morales Meseguer, Murcia, 30008 | Status Recruiting | Site Contact Details |
Location Hospital Universitario Virgen Macarena, Sevilla, 41009 | Status Recruiting | Site Contact Details |
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. Since in most cases CLL remains an incurable disease, the goals of therapy are to improve quality of life and to prolong survival. This study will evaluate the participant's related outcomes and experience of CLL in adult participants who are treated in the Spain. Study participants will receive oral treatments for CLL as prescribed by their study doctor in accordance with approved local label. Adult participants prescribed various treatments will be enrolled. Around 132 participants will be enrolled in the study in sites in Spain. Participants will receive oral treatments for CLL according to the approved local label. The overall study duration will be 18 months. There is expected to be no additional burden for participants in this trial. All study visits will occur during routine clinical practice.
Change in Participant Functioning Measured Using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) with the EORTC Chronic Lymphocytic Leukemia 17 (EORTC-CLL17) Supplement
Time Frame: Up to 27 Months
Change in Participant Health-related Quality of Life (HRQoL)Measured Using the EORTC QLQ-C30 with the EORTC-CLL17 Supplement
Time Frame: Up to 27 Months
Interventions:
Enrollment:
132
Watch a video to learn more about what you may experience as a clinical trial volunteer: /resources/what-happens-in-a-clinical-trial
Take a virtual reality screening visit tour to an example of a clinical trial site: /resources/screening-visit-virtual-tour
Use a questionnaire tool to think through questions to ask yourself about participating in a clinical trial and print out your responses to discuss with your partners in your health journey: /resource-information-clinical-trial-community/decision-counselor
AbbVie Clinical Trials is designed to support, inform, and help patients in a clinical study or those who are interested in participating.
Please note that the information on this website is intended for informational purposes only and should not be used as a substitute for seeking medical advice or treatment from a healthcare professional. You should not use this information to diagnose or treat a medical condition or health problem. Speak to a healthcare professional if you have any questions about your health, medical condition, symptoms, or treatment options.
Copyright © 2024 AbbVie Inc.